236 related articles for article (PubMed ID: 215525)
1. Epstein-Barr virus-related serology in nasopharyngeal carcinoma and controls.
Henle W; Henle G; Ho JH
IARC Sci Publ (1971); 1978; (20):427-37. PubMed ID: 215525
[No Abstract] [Full Text] [Related]
2. [Value of anti-Epstein-Barr antibody detection in the diagnosis and management of undifferentiated carcinoma of the nasopharynx].
Mazeron MC
Bull Cancer Radiother; 1996; 83(1):3-7. PubMed ID: 8679277
[TBL] [Abstract][Full Text] [Related]
3. Nasopharyngeal carcinoma: significance of changes in Epstein-Barr virus-related antibody patterns following therapy.
Henle W; Ho JH; Henle G; Chau JC; Kwan HC
Int J Cancer; 1977 Nov; 20(5):663-72. PubMed ID: 200569
[No Abstract] [Full Text] [Related]
4. Presence of Epstein-Barr virus specific IgA in saliva of nasopharyngeal carcinoma patients: their activity, origin and possible clinical value.
Desgranges C; de-The G
IARC Sci Publ (1971); 1978; (20):459-69. PubMed ID: 215528
[No Abstract] [Full Text] [Related]
5. Clinical evaluation of EBV serology in American patients with nasopharyngeal carcinoma.
Pearson GR; Coates HL; Neel HB; Levine P; Ablashi D; Easton J
IARC Sci Publ (1971); 1978; (20):439-48. PubMed ID: 215526
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.
Oberender H; Nowak R; Donner A; Kunkel M; Gärtner L; Scholtz HJ
Acta Virol; 1983 May; 27(3):277-81. PubMed ID: 6138990
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of antibodies to Epstein-Barr virus in Italian patients with nasopharyngeal carcinoma.
Cevenini R; Donati M; Caliceti U; Moroni A; Tamba I; Rumpianesi F
J Infect; 1986 Mar; 12(2):127-31. PubMed ID: 3009628
[TBL] [Abstract][Full Text] [Related]
8. [Value of Epstein-Barr virus serology during radiotherapy of undifferentiated carcinoma of the nasopharynx].
Yomi J; Fouda A; Fossi A; Bejanga B
Bull Cancer Radiother; 1996; 83(3):168-9. PubMed ID: 8977568
[No Abstract] [Full Text] [Related]
9. [Rhinopharyngeal carcinoma and Epstein-Barr virus: study of a sample of Italian patients].
Caliceti U; Cevenini R; Donati M
Acta Otorhinolaryngol Ital; 1985; 5(1):83-90. PubMed ID: 2994355
[No Abstract] [Full Text] [Related]
10. The capsid antigen of Epstein-Barr virus in nasopharyngeal carcinomas: comparison of serum antibody titre, cellular antigen content and histopathology.
Falser N
Arch Otorhinolaryngol; 1984; 239(1):15-23. PubMed ID: 6318710
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of antibodies to Epstein-Barr virus DNase and viral capsid antigen for prognostication of patients with nasopharyngeal carcinoma.
Hsu MM; Chen JY; Chen CJ
Taiwan Yi Xue Hui Za Zhi; 1988 Oct; 87(10):984-8. PubMed ID: 2853721
[No Abstract] [Full Text] [Related]
12. The genetic and antigenic basis for the IgA antibody response to Epstein-Barr viral capsid antigen.
Ng MH; Ho HC; Kwan HC
IARC Sci Publ (1971); 1978; (20):449-58. PubMed ID: 215527
[No Abstract] [Full Text] [Related]
13. Auto-antibodies in the sera of patients with nasopharyngeal carcinoma.
Yoshida TO; Yasuda-Yasaki Y; Utsumi KR
IARC Sci Publ (1971); 1975; (11 Pt 2):259-73. PubMed ID: 191369
[No Abstract] [Full Text] [Related]
14. Circulating immune complexes in patients with nasopharyngeal carcinoma.
Wolf GT; Wolfe RA
Laryngoscope; 1990 Mar; 100(3):302-8. PubMed ID: 1689798
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus is not associated with head and neck neoplasms other than nasopharyngeal carcinoma.
Kottaridis SD; Goula I; Kiparissiadis P
Neoplasma; 1982; 29(3):327-31. PubMed ID: 6290911
[No Abstract] [Full Text] [Related]
16. Malaria antibody levels in patients with nasopharyngeal carcinoma.
Yadav M; Prasad U
Southeast Asian J Trop Med Public Health; 1984 Jun; 15(2):234-7. PubMed ID: 6095462
[TBL] [Abstract][Full Text] [Related]
17. Differences in EBV antibody titres of patients with nasopharyngeal carcinoma originating from high, intermediate and low incidence areas.
de-The G; Lavoue MF; Muenz L
IARC Sci Publ (1971); 1978; (20):471-81. PubMed ID: 215529
[TBL] [Abstract][Full Text] [Related]
18. [The clinical usefulness of the serological study of IgG antibodies and IgA against the antigens associated with the Epstein-Barr virus in patients with nasopharyngeal carcinoma].
Amador García JM; Mendoza Montero J; Expósito Hernández J; Salinero Hernández J; Esquivias López-Cuerpo J; Ballesteros García P
Acta Otorrinolaringol Esp; 1992; 43(1):31-6. PubMed ID: 1316136
[TBL] [Abstract][Full Text] [Related]
19. Serological and immunohistological assessment of Epstein-Barr virus infection in Sicilian patients with suspected nasopharyngeal carcinoma.
Ammatuna P; de Thè G; Speciale R; Sammartano F; Arista S; Zerillo G
Microbiologica; 1988 Apr; 11(2):89-94. PubMed ID: 2841559
[TBL] [Abstract][Full Text] [Related]
20. Histological types of nasopharyngeal carcinoma in an intermediate risk area.
Cammoun M; Ellouz R; Behi J; Attia RB
IARC Sci Publ (1971); 1978; (20):13-26. PubMed ID: 215511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
